miR-155 and miR-92 levels in ALL, post-transplant aGVHD, and CMV: possible new treatment options

CONCLUSION: Our study suggests that the plasma signature of microRNA expression may act as a powerful marker for diagnosis and prognosis, providing knowledge outside cytogenetics. Elevation of miR-155 in plasma can be a beneficial therapeutic target for ALL patients, with consideration of higher plasma levels of miR-92 and miR-155 in CMV + and post-HSCT aGVHD patients.PMID:37332027 | DOI:10.1186/s43046-023-00174-3

Source: J Egypt Natl Canc In... - June 18, 2023 Category: Cancer & Oncology Authors: Mahdiyar Iravani Saadi Mohsen Nikandish Zahra Ghahramani Fatemeh Mardani Valandani Maryam Ahmadyan Fakhroddin Hosseini Zahra Rahimian Heeva Jalali Fataneh Tavasolian Ehsan Nabi Abdolyousefi Nadiya Kheradmand Mani Ramzi Source Type: research